Envoy Medical, Inc Warrant closed at $0.03 on Sep 24, up 4.97%, 62.9% below its highest close since Oct 2. Volume of 100 shares was 0.00× its 20-day average (below normal).
Split-adjusted performance: +1.9% over one month, -52.5% over six months.
In the quarter ended Jun 30, 2026, revenue was $51K, down 34.6% from a year earlier, with a net margin of -14258.8%.
Short interest was 32.3K shares at the Sep 15 settlement, down 54.3% from the prior report (1.0 days to cover).